ALLIANCE FOR BIOPHARMACEUTICAL COMPETITIVENESS AND INNOVATION

Lobbying client · District of Columbia · filed 2025 to 2026

Biopharmaceutical industry

$1,990,000 Reported spend

7 Filings counted

1 Outside firm hired

12 Bills named

Spend is reported income plus in-house expenses across 7 filings. Everything on this page comes from one LDA client record (179012), filed by the registrant listed below.

Who filed for this client 1

THE WASHINGTON TAX & PUBLIC POLICY GROUP $1,990,000 Outside firm · 7 filings

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

Bills named in these filings 12

H.R. 1062
Growing and Preserving Innovation in America Act of 2025

4 filings
H.R. 1347
AIMM Act

4 filings
H.R. 1990
American Innovation and R&D Competitiveness Act of 2025

4 filings
H.R. 574
ALIGN Act

4 filings
S. 187
ALIGN Act

4 filings
S. 559
AIMM Act

4 filings
H.R. 1
One Big Beautiful Bill Act

3 filings
S. 1605
International Competition for American Jobs Act

3 filings
S. 1688
Growing America’s Small Businesses and Manufacturing Act

3 filings
S. 2021
Close the Round-Tripping Loophole Act

3 filings
S. 1639
American Innovation and Jobs Act

2 filings
H.R. 10431
U.S. Innovation and Global Competitiveness Act of 2026

1 filing

Reported by year 2 years

2026 $950,000 3 filings
2025 $1,040,000 4 filings

Issues lobbied 1

Taxation/Internal Revenue Code 7

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 3

HOUSE OF REPRESENTATIVES 7
SENATE 7
Treasury, Dept of 1

Recent filings 7 total

Q3 report

THE WASHINGTON TAX & PUBLIC POLICY GROUP

3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $400,000 income · posted Oct 16, 2026

View → Q2 report

THE WASHINGTON TAX & PUBLIC POLICY GROUP

2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $50,000 income · posted Jul 9, 2026

View → Q1 report

THE WASHINGTON TAX & PUBLIC POLICY GROUP

1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $500,000 income · posted Apr 1, 2026

View → Q4 report

THE WASHINGTON TAX & PUBLIC POLICY GROUP

4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $70,000 income · posted Jan 13, 2026

View → Q3 report

THE WASHINGTON TAX & PUBLIC POLICY GROUP

3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $450,000 income · posted Oct 14, 2025

View → Q2 report

THE WASHINGTON TAX & PUBLIC POLICY GROUP

2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $70,000 income · posted Jul 8, 2025

View → Q1 report

THE WASHINGTON TAX & PUBLIC POLICY GROUP

1st Quarter 2025 (Jan 1 - Mar 31) · House · Senate · $450,000 income · posted Apr 8, 2025

View →

Keep going

Filings through October 16, 2026, the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.